eli lilly glp-1 advantage decreasing Overview of GLP-1s A Big Week for GLP-1

Dulaglutide Dulaglutide (Trulicity) is administered subcutaneously at a maximum dose of 1.5 mg once weekly, and available on license since 2014 for people with T2D as monotherapy in those who cannot take metformin or as add-on treatment in people using oral agents and/or insulin

[PMID: 9733495] PubMed record related to this compound for laboratory literature review

Staining controls included cells stained with appropriate isotype control antibodies (Mouse IgG2a negative control: RPE clone OX-34, Mouse IgG2b negative control: FITC, A647, Mouse IgG1 negative control: FITC, Mouse IgG3 negative control: RPE) purchased from AbD serotec, Bio-Rad laboratories GmbH, Feldkirchen, Germany

Jest hydrofilowy, dobrze miesza si z wodnymi buforami i zachowuje si stabilnie w kontrolowanym zakresie pH dziki czemu bywa wybierany jako materia odniesienia w prostych ukadach in vitro